Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
D000328:Adult; D000965:Antimony / Q000009:adverse effects*; D000967:Antimony Sodium Gluconate / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D005260:Female; D005942:Gluconates / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007684:Kidney Tubules / Q000187:drug effects; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy*; D008297:Male; D008536:Meglumine; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds
D000981:Antiprotozoal Agents; D005942:Gluconates; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony; D000967:Antimony Sodium Gluconate